Related Experiment Video
Updated: May 15, 2026

Using Caenorhabditis elegans as a Model System to Study Protein Homeostasis in a Multicellular Organism
Published on: December 18, 2013
Protein homeostasis as a therapeutic target for diseases of protein conformation
Barbara Calamini1, Richard I Morimoto
1Department of Neurobiology and Center for Drug Discovery, Duke University, Durham, NC, USA.
Abstract:
Protein misfolding and aggregation are widely implicated in an increasing number of human diseases providing for new therapeutic opportunities targeting protein homeostasis (proteostasis). The cellular response to proteotoxicity is highly regulated by stress signaling pathways, molecular chaperones, transport and clearance machineries that function as a proteostasis network (PN) to protect the stability and functional properties of the proteome. Consequently, the PN is essential at the cellular and organismal level for development and lifespan. However, when challenged during aging, stress, and disease, the folding and clearance machineries can become compromised leading to both gain-of-function and loss-of-function proteinopathies. Here, we assess the role of small molecules that activate the heat shock response, the unfolded protein response, and clearance mechanisms to increase PN capacity and protect cellular proteostasis against proteotoxicity. We propose that this strategy to enhance cell stress pathways and chaperone activity establishes a cytoprotective state against misfolding and/or aggregation and represents a promising therapeutic avenue to prevent the cellular damage associated with the variety of protein conformational diseases.
Insights
Targeting protein homeostasis (proteostasis) by enhancing cellular stress responses and molecular chaperone activity offers a promising therapeutic strategy. This approach aims to protect against protein misfolding and aggregation in various diseases.
Area of Science:
- Molecular Biology
- Cellular Biology
- Pharmacology
Background:
- Protein misfolding and aggregation are linked to numerous human diseases, creating a need for novel therapeutic targets.
- The proteostasis network (PN) maintains proteome stability through stress signaling, molecular chaperones, and clearance systems.
- Aging, stress, and disease can impair PN function, leading to protein conformational diseases.
Purpose of the Study:
- To investigate small molecules that can enhance the proteostasis network (PN) capacity.
- To assess the potential of activating cellular stress responses and clearance mechanisms as a therapeutic strategy.
- To protect cellular proteostasis against proteotoxicity and prevent damage in protein conformational diseases.
Main Methods:
- Assessment of small molecules that activate the heat shock response.
- Evaluation of compounds that stimulate the unfolded protein response.
- Analysis of agents that enhance protein clearance mechanisms.
Main Results:
- Small molecules can activate key cellular stress pathways, including the heat shock and unfolded protein responses.
- Enhanced chaperone activity and clearance mechanisms increase the cell's capacity to manage proteotoxicity.
- This strategy establishes a cytoprotective state against protein misfolding and aggregation.
Conclusions:
- Enhancing the proteostasis network through small molecules is a viable therapeutic approach.
- Activating cell stress pathways and chaperone activity offers protection against protein conformational diseases.
- This strategy represents a promising avenue for preventing cellular damage in diseases associated with protein misfolding.
Related Concept Videos
Protein Denaturation
Protein Folding
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Folding
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

